Table of Contents
Analgesics in Hungary
Euromonitor International
May 2009
List of
Contents and Tables
Executive Summary
Trend Towards Self-medication
Drives Modest Market Development in 2008
Chemists/pharmacies Continue To
Dominate OTC Healthcare Distribution
Competitive Landscape in Analgesics
Shifts Following 2007 Switches
Deregulation Leads To More Intense
Competition in Chemists/pharmacies
Self-medication Trend Will Continue To
Benefit OTC Healthcare Over 2008-2013
Key Trends and Developments
Economic and Political Problems Inhibit OTC Healthcare Performance
OTC
Healthcare Distribution Outside Chemists/pharmacies Is Slow To Take Off
Algoflex Attempts To Fill the Space Vacated by Algopyrin in Analgesics
Pharmacy Deregulation Improves OTC Healthcare Distribution
Hungarians
Continue To Live Unhealthy Lifestyles
Market Indicators
Table 1
Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table
2 Life Expectancy at Birth 2003-2008
Market Data
Table 3 Sales of OTC
Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by
Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by
Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Penetration of Private Label by Sector 2003-2008
Table 8 Sales of
OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 9 Sales
of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table
10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 11
Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
Appendix
OTC Registration and Classification
Advertising
Packaging
Labelling
Distribution
Vitamins & Dietary Supplements
Registration and Classification
EU Legislation
Self-medication and
Preventative Medicine
Generics
Switches
Summary 1 OTC Healthcare
Switches: 2005-2007 (note: re-switch: the status of drugs was changed formerly
from Rx to OTC, and current re-switch changed
Definitions
Summary 2
Research Sources
Egis Rt
Strategic Direction
Key Facts
Summary
3 Egis Rt: Key Facts
Summary 4 Egis Rt : Operational Indicators
2005-2007
Company Background
Production
Competitive
Positioning
Summary 5 Egis Rt: Competitive Position 2008
Extractum-pharma Rt
Strategic Direction
Key Facts
Summary 6
Extractum-Pharma Rt: Key Facts
Summary 7 Extractum-Pharma Rt: Operational
Indicators 2005-2007
Company Background
Production
Competitive
Positioning
Summary 8 Extractum-Pharma Rt: Competitive Position 2008
Pannonpharma Kft
Strategic Direction
Key Facts
Summary 9
PannonPharma Kft: Key Facts
Summary 10 PannonPharma Kft: Operational
Indicators 2005-2007
Company Background
Production
Competitive
Positioning
Summary 11 PannonPharma Kft: Competitive Position 2008
Richter Gedeon Rt
Strategic Direction
Key Facts
Summary 12 Richter
Gedeon Rt: Key Facts
Summary 13 Richter Gedeon Rt: Operational Indicators
2005-2007
Company Background
Production
Competitive
Positioning
Summary 14 Richter Gedeon Rt: Competitive Position 2008
Teva Magyarország Rt
Strategic Direction
Key Facts
Summary 15
Teva Magyarország Rt: Key Facts
Summary 16 Teva Magyarország Rt:
Operational Indicators 2005-2007
Company Background
Production
Competitive Positioning
Summary 17 Teva Magyarország Rt: Competitive
Position 2008
Headlines
Trends
Switches
Competitive
Landscape
Prospects
Sector Data
Table 12 Sales of Analgesics by
Subsector: Value 2003-2008
Table 13 Sales of Analgesics by Subsector: %
Value Growth 2003-2008
Table 14 Herbal vs Standard Topical Analgesics
2003-2008
Table 15 Topical Analgesics by Format: % Value Breakdown
2004-2008
Table 16 Analgesics Company Shares by Value 2004-2008
Table
17 Analgesics Brand Shares by Value 2005-2008
Table 18 Forecast Sales of
Analgesics by Subsector: Value 2008-2013
Table 19 Forecast Sales of
Analgesics by Subsector: % Value Growth 2008-2013
| 
View Cart
